Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12464307 | 0.81 | PIM1 (0.34) | KDM4EGAA | |
| SCHEMBL15806842 | 0.81 | OPRM1 (0.33) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL12464686 | 0.81 | OPRM1 (0.33) | OPRM1OPRD1OPRK1PRMT1 | |
| SCHEMBL15806845 | 0.80 | HRH1 (0.34) | OPRM1KDM4E | |
| SCHEMBL16079858 | 0.79 | — | — | |
| SCHEMBL12464309 | 0.78 | OPRM1 (0.34) | OPRM1OPRD1OPRK1 | |
| SCHEMBL12395733 | 0.76 | OPRM1 (0.30) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL13082726 | 0.75 | KDM4E (0.36) | OPRM1OPRD1OPRK1KDM4EGAA | |
| SCHEMBL90746 | 0.75 | PARP1 (0.32) | — | |
| SCHEMBL14586042 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110183938-A1 | 1,7-DIAZACARBAZOLES AND METHODS OF USE | GENENTECH, INC. (US) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183938-A1 | 1,7-DIAZACARBAZOLES AND METHODS OF USE | CHEK1, CHEK2, BUB1B | OPRM1 4884/4885OPRD1 4847/4885OPRK1 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.